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Abstract
Throughout this thesis we will analyze the reaction in the growth rate of COVID-19
related hospitalizations following the implementation of Non-Pharmaceutical Interventions
(NPIs), in order to estimate their effectiveness. Additionally, our thesis will investigate the
effect of specific NPIs, and the difference in NPI performance throughout the pandemic.
Although previous studies have focused on the reproduction number R, case growth, and
cumulative deaths as their dependent variable, our thesis focuses on the number of daily
COVID-19 related hospitalizations. We believe this to be a more reliable indicator of the
spread of infection within the population. In doing so, we use a moving average of daily
COVID-19 related hospitalizations as our dependent variable in our analysis.
In order to carry out our analysis, we conduct our first regression on 64 events of NPI
implementation. We undertake this regression in order to compute the difference in the
growth rate of COVID-19 related hospitalizations, before and after NPI implementation.
Furthermore, to conduct our second regression, we use the effect of each NPI in place as
our dependent variable, which utilizes dummy variables for each active group of NPIs in
order to find the effect of each NPI group. Lastly, our concluding regression introduces a
final variable to determine if NPIs are getting increasingly more effective throughout the
pandemic.
For our conclusion, we determine from the results of our event studies that not all NPI
implementations were successful, and that the outcome of our second regression indicates
that there are extensive differences in the effectiveness of NPIs. We understood from our
regression that school closures and lockdown measures are the most effective NPI in order
to reduce the growth rate in COVID-19 related hospitalizations. Furthemore, we conclude
that the implementation of these NPIs was more effective in reducing the growth rate of
COVID-19 related hospitalizations during the first wave of infection.
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1 Introduction
1.1 Background and Motivation
In the first months of 2020, the COVID-19 pandemic upended life as we knew it. Due
to its highly infectious nature, COVID-19, caused by the severely acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), threatened to overwhelm the healthcare systems
of countries worldwide. To respond to this imposing threat, many countries imposed
Non-Pharmaceutical Interventions (hereafter known as NPIs) to reduce the spread of the
virus. Some of these NPIs include: limitations and bans on private and public gatherings,
school- and business closures, and travel restrictions. In a desperate attempt to reduce the
rising infection rates, governments shut down societies overnight. The COVID-19 virus
forced governments worldwide to take action, and although there were many similarities
in how they did so, there were also many differences. Even within the European Economic
Area, governments responded differently. Firstly, a factor that might have contributed to
why they did is the general lack of preparation. Secondly, many governments predicted
that long-lasting restrictions and lockdowns would result in vast economic costs. Finally,
based on the available data on the virus, scientists and epidemiologists believed that
there was not enough scientific basis for closing down society. While some governments
decided to follow “the precautionary principle” and close down, others followed the advice
of their scientific experts. Exemplified by Sweden and the famous quote made by their
epidemiologist to international journal Nature (Paterlini, 2020):
“Closedown, lockdown, closing borders - nothing has a scientific basis, in my view. We
have looked at a number of European Union countries to see whether they have published
any analysis of the effects of these measures before they were started and we saw almost
none.” - Anders Tegnell, Swedish state epidemiologist
These different types of responses to the virus prompted our curiosity, and drove us to
investigate the effectiveness of NPIs. In order to do so, we will estimate the effect that
NPIs have on the growth rate of COVID-19 related hospitalizations.
2 1.2 Hypotheses
Our studys’ research question is:
How effective are Non-Pharmaceutical Interventions in reducing the spread of COVID-19
and thereby hospitalization numbers?
The answer to this question can be of substantial interest to government officials and
health authorities, who would be responsible for NPI implementations in future virus
outbreaks. Additionally, the negative impacts of NPIs are numerous, and for an accurate
cost-benefit analysis, the effectiveness of NPIs are a crucial input. In the next section of
our introduction, we present the hypotheses we have constructed to efficiently answer our
research question.
1.2 Hypotheses
To thoroughly analyze our data and answer our research question, we define three specific
hypotheses and elaborate on our expectations for the results.
Hypothesis 1: All events of NPI implementation during increasing growth rate in
COVID-19 related hospitalizations will result in a reduced growth rate when the NPIs are
expected to be effective.
Our hypothesis suggests that we will see an apparent reduction in the growth rate of
COVID-19 related hospitalizations when the introduced NPIs are expected to be effective.
Hypothesis 2: The introduction of any NPI effectively reduces the growth rate of COVID-
19 related hospitalizations, yet some NPIs are more effective than others.
We believe that the introduction of any of the NPIs in our sample effectively reduces the
growth rate in hospitalizations. However, we hypothesize that some of our NPIs will be
significantly more effective to reduce the growth rate of COVID-19 related hospitalizations
than others. We predict that this will be especially present for the more intrusive NPIs,
meaning that we expect a greater growth rate reduction for highly restrictive measures.
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Hypothesis 3: Events of NPI implementation in the later stages of the pandemic are
more effective in reducing hospitalizations than events in the first wave.
Our final hypothesis states that events of NPI implementation in later stages of the
pandemic are more effective than those in the first wave. We base this hypothesis on the
belief that governments with more substantial information and knowledge about the virus
should make better decisions in NPI introduction.
1.3 Structure
The remaining content of our thesis is structured as follows. The following section will
consist of a review of relevant literature and an introduction of fundamental concepts. The
third section will elaborate on our data collection process and further present our final
sample after filtering out the appropriate and trustworthy data in our sample description
section. The fourth section will dive into the event study methodology and elaborate on
the supplementary theoretical framework. Further, the fifth section will consist of our
empirical results, where we will present and discuss the results of our regressions. In the
following sixth section, we will conduct different robustness tests to see how adjustments
in our model specifications will affect our event regression coefficients. Additionally, in
the seventh part of our thesis, we will summarize our results and conclude whether our
analysis findings align with our original hypotheses. Lastly, the final sections of our thesis
will present the limitations of our study, followed by our references and appendix.
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2 Literature Review & Fundamental Concepts
This section of our thesis starts by conducting a literature review on previously conducted
research relevant to our study. Furthermore, we present fundamental concepts necessary
to have a maximized benefit of our thesis. Based on our research, there have been no
studies estimating the effects of Non-Pharmaceutical Interventions on hospitalizations in
a large sample of European countries. This section will help clarify the contributions of
our research.
2.1 Literature Review
As mentioned in the introduction to this thesis, an argument against lockdown or the
use of NPIs is the lack of scientific basis for it. Although this is an argument that is less
common now than it was in the early stages of the pandemic, it is an argument that
is important to present. In early 2020, there was little knowledge on dealing with the
COVID-19 virus, as there was still uncertainty on its infectiousness and mortality rate.
Now that the pandemic has passed its one-year mark, the publications and scientific
basis are rapidly increasing in scope. As the pandemic has been the dominating factor
in the news, economics, and everyday life, the number of reports made by scientists,
universities and governments has drastically expanded. A COVID-19 response team
from Imperial College added to the research on estimating reproduction numbers and
measuring the impact of social distancing measures on 11 European countries (Ferguson
et al., 2020). They compare the prediction of epidemiological modeling estimated on data
before intervention to actual outcomes across the different countries, using the number of
COVID-19 related deaths to compare the effects. The main contribution from their work,
that we use in our thesis, is the estimation of the interval from the introduction of NPIs
until the NPIs have an impact on hospital numbers (Ferguson et al., 2020). The response
team found the interval between infection and reduction in hospitalization to vary from 2
to 3 weeks, which will be an essential estimate in our analysis.
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Currently, there are numerous studies available regarding COVID-19 response measures
and the use of NPIs. Yet, there is no clear consensus on which NPIs are more efficient.
Therefore isolating the effects of the different NPIs would be a valuable addition to the
overall research on the subject. Flaxman et al. (2020) conducted a study to estimate
the effectiveness of five categories of NPIs on the spread of COVID-19 in 11 countries.
The five categories they looked at were social distancing encouraged, self isolation, school
closures, public events banned, and complete lockdown. As an indication for the number
of people infected, they use mortality data collected between January and early May 2020.
They concluded that only one of these NPI categories, the lockdown, had been effective in
10 out of the 11 European countries studied.
The research conducted by Bendavid et al. (2021) evaluates the effects of NPIs on epidemic
growth, and separates the effect of more restrictive NPIs to those less restrictive.The
research takes into consideration ten countries within the EU, South Korea, Iran and the US.
The data used in the study is daily case numbers reported by subnational administrative
regions of each country merged with the type and timing of policies in each administrative
area (Bendavid et al. 2021). This data relies upon equal and correct reporting on a
regional level. The implementation of any NPI was associated with significant reduction in
case growth in 9 out of 10 countries. In conclusion, the paper did not find notable benefits
that the more restrictive NPIs would have on limiting cases’ growth numbers. Comparable
reductions in case growth may be achievable with less-restrictive interventions.
The work of this thesis is also influenced by Juranek and Zoutman (2020) and their
case study on the use of NPIs within the Scandinavian countries. In their difference-in-
difference approach, Sweden serves as a counterfactual to Denmark and Norway due to
Sweden being the only country that had not initiated strict lockdown measures. Limited
to the Scandinavian countries, they find the more stringent measures reduce the number
of hospitalizations and intensive care patients per capita, thereby decreasing the stress on
the health care system.
6 2.2 Fundamental Concepts
Our thesis contributes to existing research by focusing on daily COVID-19 related
hospitalizations as our dependent variable, as was used in the paper by Juranek and
Zoutman (2020). A new perspective relative to the other studies mentioned above that
analyze the effectiveness of NPIs with the reproduction number R, case growth and
cumulative deaths. We believe that daily hospitalizations might be a more reliable
estimate, as hospitals and health authorities have a great capacity for accurate registration
of COVID-19 related hospitalizations. Hospitalized patients are also likely to be tested
in all countries, as they will experience severe symptoms. Other measures, such as the
number of confirmed infections, are likely to be affected by measurement error due to
differences in the testing regime between the countries (Juranek & Zoutman, 2020).
Another contribution to the existing research is our use of the event study methodology
and the manual identification of NPI implementation events. Additionally, the use of
the pre- vs. post-treatment comparison in our event studies is different from most
comparable studies, as most usually conduct event studies with treatment groups and
difference-in-difference models. The pre- vs. post-treatment comparison does not require
any assumptions regarding control groups. This trait enables us to include a larger
number of events and groups than previous research to reduce the systematic time-varying
components within countries, permitting us to isolate the effect of each NPI.
2.2 Fundamental Concepts
Within this section, we will provide information on Non-Pharmaceutical Interventions
(NPIs) and COVID-19 disease progression. We will present the definition of Non-
Pharmaceutical Interventions and elaborate on the use of NPIs to reduce the spread of a
pandemic virus. The following COVID-19 disease progression section will substantiate the
reasoning behind the time frames in our event study. The section will present estimates
on the time frame between the initial COVID-19 infection and hospitalization.
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2.2.1 Non-Pharmaceutical Interventions
Non-Pharmaceutical Interventions (NPIs) are defined by the Centers for Disease Control
and Prevention (2020) as “actions, apart from getting vaccinated and taking medicine,
that people can take to help slow the spread of illnesses like pandemic influenza”. In
other words, NPIs are interventions or restrictions that national authorities pose on
communities to decelerate the spread of a virus. These restrictions are commonly referred
to as lockdowns, response measures, and measures of social distancing. The use of NPIs
is pivotal to reduce the spread of a virus. Particularly in the case of new viruses, like
COVID-19, where the population has little or no immunity against it (CDC, 2021).
2.2.2 COVID-19 Disease Progression
In order to accurately measure the effects of NPIs, we find it necessary to determine the
median time from a COVID-19 outbreak to a significant increase in the growth rate of
hospitalizations. This would provide us with an accurate estimate of the time interval
from NPI implementation to a reduction in the growth rate in hospitalizations. This
measure is found by the following equation:
Median incubation time
+ Median time from symptom onset to hospitalization
+ Median time hospitalized
=Median time from transmission to a significant increase in the growth rate
of hospitalizations
The measurements are found in an article by the American College of Physicians Public
Health Emergency Collection (Lauer et al., 2020). This data is collected from the initial
coronavirus outbreak in the Hubei province in China prior to February 24th, 2020. The
article found that the median incubation period was estimated to be 5.1 days, with a
95% confidence interval of 4.5 to 5.8 days. In the study, among those who developed
symptoms, the median time from symptom onset to hospitalization was 1.2 days. These
results indicate a median time from transmission to hospitalization of 6.3 days.
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The last factor, the average time hospitalized has been the most challenging component
to detect, as there has been considerable difference in estimates. In a report published by
the Norwegian Public Institute of Health the results suggest an average hospitalization
time of around 8.7 days during the first months of the pandemic. However, this estimate
drops to 7.6 from June 2020 to January 2021 (NPIH, 2021), with the knowledge that
treatment was the probable determining factor of this reduction.
Our thesis investigates the reduction in the growth rate of COVID-19 related
hospitalizations. It is therefore important to estimate the time interval from when
NPIs are implemented, until when we expect to see a significant effect on the growth rate
of hospitalizations. The median time from transmission to hospitalization is 6.3 days, and
the estimated time hospitalized is approximately 8 days. As our estimations are based on
7-day moving averages of hospitalizations, we will therefore not be able to see a significant
effect on the growth rate until the hospital discharges outweigh the influx of patients.
Therefore, we believe the findings of the Imperial College response team of 2-3 weeks from
NPI implementation until NPI effect to be an accurate estimate (Ferguson et al., 2020).
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3 Data Collection and Sample Description
The data sample studied in this thesis consists of the daily hospitalization data from
24 countries from March 2020 to March 2021. The sample further includes data on all
Non-Pharmaceutical Interventions implemented in Europe during the same time frame.
This section will elaborate on our data collection and selection process. In the development
of our final sample we have encountered challenges in collection, reliability and coherence.
The following subsections will show how we have encountered these impediments and how
we are able to minimize their influence.
3.1 Data on Daily Hospitalized COVID-19 Patients
The data on “Daily Hospitalized Patients” has been the most arduous part of the data
collection process. This was a challenge for us because the data has been unavailable for
many European countries and non-existent for others. There has been no sole data source
that has collected and made this data available. While most of the data were collected
from Our World in Data, outliers and missing data from specific countries have been
found elsewhere (OWID, 2021). A large portion of the data is collected separately from
individual sources, namely health departments and institutes of the sampled countries.
Although a single source would have been beneficial, directly collecting data from individual
government websites can add to the reliability of the data itself.
However, there is uncertainty within the individual countries’ accuracy in recording
daily hospitalized COVID-19 patients, as their method of hospitalization registration
differs. This is because many countries do not register on a daily basis, or over weekends.
Considering that the daily hospitalized COVID-19 patients is an uncertain estimate, all
our analysis is based on a 7-day moving average. This is to avoid the issue of outliers and
missing values and account for the differences in registering. The 7-day moving average
for COVID-19 related hospitalizations for each country is presented in the figures below:
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Figure 3.1: Hospital Occupancy in European Countries Per Million
For the purpose of enhancing the credibility of our analysis, during our data collection
process, we have been in contact with numerous health authorities of different European
countries. We did so in order to collect data and acquire information on the data already
available in our sample
3.2 The Response Measures Data
To test the effect of different comparable Non-Pharmaceutical Interventions, it is necessary
to find data that has assembled and compared different NPIs across different European
countries. The data is found at the European Centre for Disease Prevention and Control
(ECDC, 2021). This dataset, which is collected from official public websites of different
countries, contains every NPI implemented in all European countries, with their respective
date ranges. The response measures data come with four disclaimers. Firstly, there is
substantial heterogeneity within measures related to physical distancing and how these
NPIs are implemented between countries, principally in the level of enforcement and
the amount of exceptions. Secondly, the response measures in the dataset are the ones
reported nationally. For most countries, if there is a significant local outbreak, regional or
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local measures precede national ones. Thirdly, the dates introduced in the data might not
be precise. It is not clearly stated whether the date presented is the date of informing the
public of impending NPIs or the actual date of NPI implementation and is in our thesis
regarded as the implementation date. Lastly, the response measures in the dataset might
be difficult to count for, because unfortunately, the COVID-19 social measures that are
no longer in force are removed from the official website. (ECDC, 2021).
Not all the measures that are shown in the dataset are relevant to our study. Therefore,
presented in Table 3.2 below are the actions taken to condense the response measures
data. Firstly, the response measures that were defined as “partially relaxed measures” were
removed from the sample. Secondly, we remove all NPIs that have been active in less than
three countries and are not similar to any other NPI. An example is the NPI Closure Of
Public Transport, which was only active in Croatia and Slovenia. Response measures with
limited observations do not provide us with reliable estimates on their efficiency and are
therefore removed. Lastly, we consolidate NPIs that we consider to be highly homogenous
and that we expect to have a limited difference in disease transmission. An example is
the NPIs that restricted large indoor gatherings. IndoorOver500and IndoorOver1000
were merged into IndoorLargeGatherings. See the measures underlined in the appendix
Measures To Identify Events for the complete sample of NPIs.
Table 3.1: NPI Cleaning
Action No. Action Taken Number of NPIs
1 All NPIs Registered in Europe 64
2 Remove Partial NPIs 36
3 Remove NPIs Active in Less Than 3 Countries 34
4 Merge NPIs Considered Too Similar 28
5 Complete Sample of NPIs 28
The complete sample of 28 NPIs is used to identify our events, which we will elaborate
on within the Identifying the NPI Events section of our thesis. It is evident that with
only 25 countries, we are unlikely to identify enough events to be able to run a regression
containing variables for all 28 NPIs in our sample. In the next section, we will correct
this matter.
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3.2.1 NPI Grouping Variables
With variables for all 28 NPIs, the explanatory power of our regression is expected to be
low. For this reason it is necessary to sort NPIs into groups in order to reduce the number
of variables. The NPI will be sorted based on similarity and intensity. Some groups are
dummy variables that are activated if one or more of the similar NPIs are active. The
remaining groups are based on intensity. That means that if few similar variables are
activated for an event a “low intensity variable” is activated, while if many similar variables
are activated the “high intensity variable” is activated. The StayHomeOrder NPI is the
only one that is a dummy variable for a singular NPI, as this is an extensive and unique
measure that does not fall within any of the other NPI groups. See the explanation for
the event groups variables below:
WorkRestrictions. Dummy variable that indicates if one of the measures
AdaptationOfWorkplace, Teleworking or WorkPlaceClosures are active. These are all
NPIs that result in the implementation of office restrictions and thereby a work-from-home
demand for most non-essential workers.
SchoolCloseLow. Dummy variable that indicates low intensity of the variables
ClosDayCare, ClosHigh, ClosPrim and ClosSec. Low intensity means that less than
three out of four of the educational institutions’ NPIs listed are active at the time of the
event.
SchoolCloseHigh. Dummy variable that indicates high intensity of the variables
ClosDayCare, ClosHigh, ClosPrim and ClosSec. High intensity means that more than two
out of four of the educational institutions’ NPIs listed are active at the time of the event.
CloseVBLow. Dummy variable that indicates low intensity of the variables
EntertainmentVenues, GymSportsCentres, HotelsOtherAccommodations,
NonEssentialShops, PlaceOfWorship and RestaurantsCafes. Low intensity means
that more than three out of six of the visitation based businesses NPIs listed are active at
the time of the event.
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CloseVBHigh. Dummy variable that indicates high intensity of the
variables EntertainmentVenues, GymSportsCentres, HotelsOtherAccommodations,
NonEssentialShops, PlaceOfWorship and RestaurantsCafes. High intensity means that
less than four out of six of the visitation-based businesses NPIs listed are active at the
time of the event.
GatheringsLow. Dummy variable that indicates if one of the measures
OutdoorLargeGatherings, IndoorLargeGatherings, MassGather are active. These are
all NPIs that put restrictions on the public gathering of large groups of people.
GatheringsHigh. Dummy variable that indicates if one of the measuresBanOnAllEvents,
OutdoorSmallGatherings, IndoorSmallGatherings, MassGather50 are active. These are
all NPIs that put restrictions on gathering of smaller groups of people.
PrivateGatherings. Dummy variable that indicates if one of the measures SocialCircle
and PrivateGatheringsRestriction is active. These are both NPIs that put restrictions on
gatherings in the private home.
StayHomeRec. Dummy variable that indicates if one of the measures StayHomeRec and
StayHomeRiskG is active. These are both NPIs that involve stay-home recommendations
for the population.
StayHomeOrder. Dummy variable that indicates if the NPI StayHomeOrder or
commonly referred to as “lockdown” is active.
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Figure 3.4: Overview of NPI Groups Implemented Per Country
3.3 Panel Data
The data set used in our thesis is a panel data set. Using a panel data set enables us
to create more extensive models and estimate more accurately the inference of model
parameters, instead of purely analyzing cross-sectional data or time series. Additionally,
in most cases, it will contain more sample variability and more degrees of freedom than
cross-sectional data. The use of cross-sectional data and time series is not relevant for our
study because we seek to analyze the change in hospital admissions over time. Therefore
our best option is to work with panel data. Our panel data refers to the time from March
2020 to March 2021. Within this range, we will isolate the effect of COVID-19 measures
variables while isolating the effect on the growth rate of daily hospitalizations as the
dependent variable.
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Panel data models sometimes include variables that vary across individuals and over time.
Additionally, they may also include variables that are constant for all individuals but
vary over time. This counts for most of our data, such as the timing of active COVID-19
response measures and hospitalization data. Finally, in many cases, models with panel
data also contain variables that vary across individuals but are constant over time. These
variables can often be difficult to observe and are referred to as unobserved heterogeneity,
which is the part of the model’s error term (Hsiao, 2006).
3.4 Pandemic Data Collection
We have collected the data used for this thesis throughout the spring of 2021, and
throughout this time, the availability of data has increased. Collecting data from
the beginning and during a pandemic has been challenging. Health departments and
hospitals register infection data in different ways. This means that the reliability of
our hospitalization data relies on the assumption that these institutions have registered
and categorized their data uniformly. Additionally, the data from the beginning of the
pandemic is uncertain and void.Therefore, in each of the individual data collection sections
above, we present measures we have taken to reduce the margin of error. For this reason,
the data we present has been cleaned to contain only values that present an appropriate
estimation. In the final part of our thesis we reflect on the limitations of our study, that
will further elaborate on the issues that occur in pandemic data collection.
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4 Empirical Methods
Within our thesis, we follow the event study methodology aligned with additional theory to
conduct our analysis. We use event studies to measure the effect of NPI implementations
on the growth rate of hospitalizations. In this section, we elaborate on the event study
methodology. Furthermore, we define our use of pre- vs. post-treatment comparison to
estimate each individual event’s effect. Lastly, we illustrate the use of OLS-regression,
and how we derive the regressions in our thesis.
4.1 Event Study Methodology
The purpose of using the event study is to observe and analyze the impact of an event
on a specific return variable before and after the event (Aktas et al., 2007). Although
the method is more commonly used in finance, the methodology has increasingly been
applied to other research areas. This is because it is easily applicable to all studies that
aim to analyze how an event affects any variable. For instance, this method has been used
to analyze the effect of the American 1971 cigarette advertising ban, and the Effect of
Social Distancing Measures on Intensive care Occupancy in 2020 (Lamdin, 1999; Juranek
& Zoutman, 2020).
Throughout our thesis, the event study methodology is applied to analyze to what extent
the introduction of different NPIs causes a reduction in the growth rate of COVID-19
related hospital admissions. The calculations are based on the estimation of growth rate
coefficients for daily COVID-19 related hospitalizations. The “before event” coefficients
will be estimated in the estimation window and serve as a counterfactual for the growth
rate, had the NPIs not been implemented. The “after event” coefficients will be estimated
in the event window. In our further analysis, the event coefficients will be used to estimate
the effects of the distinctive NPI groups presented in our Data Collection and Sample
Description section.
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4.1.1 Defining The Events and Identify The Time Periods
The first step in conducting an event study is to define the event (or events) of interest and
establish which surrounding time frames are to be included in the event study (Campbell
et al., 1997). An event in this thesis is defined as the day on which the implemented NPIs
are expected to affect the growth rate in COVID-19 related hospitalizations. Although
in finance, the event date usually refers to the day of a shock creating announcement,
the nature of the COVID-19 virus does not allow us to use the announcement of NPI
implementation as our event date. The logic behind this is outlined in Section 2.2.2 of
our thesis, as there is a time lag from the NPI implementation to the time of expected
NPI effect.
As illustrated in Figure 4.1 below, in our further analysis, we will treat the “fifteen days
after the implementation of NPIs” as our event/effect date. The two weeks between
NPI implementation and the event/effect date will function as our estimation window.
Furthermore, the two weeks following our event/effect date will function as our event
window. The following subsections will elaborate on the calculations of the event study
windows.
Figure 4.1: Event Study Timeline
Identifying the NPI Events
The first part of the event study is to identify the events. In our thesis a drastic increase in
the number of active NPIs is the first defining criteria in order to identify an event, where
all increases of more than 2 NPIs during a short day-span is considered drastic. The full
sample of the NPIs used in our event identification process are presented in our appendix,
and consists of a total of 28 NPIs. The NPIs might sometimes be introduced over a
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number of days, often irregularly and without any apparent plan behind it. Therefore, if
the introduced measures are spread over a limited number of days, the event date will be
chosen based on the median day of implementation.
The second important criteria for event identification is that the NPIs are introduced
during a period of rising infection. In other words, when the growth rate of COVID-19
related hospitalizations are increasing. We chose this as a criteria in order to exclude
events where NPIs are introduced as relaxing measures to others NPIs. These events
would potentially cloud the data, because the estimation period could include a time span
of decreasing hospitalizations, and the event period an interval of increasing/flat rates of
hospitalization. It is also important to note that the introduction of new NPIs during
a period of decreasing infection often occurs closer to the summertime, where there is
an apparent seasonal effect on the spread of the virus. As seen in our raw data and on
the online medical information cite Medscape that estimates a peak infection period for
coronaviruses from December to April (Meneghetti, 2020).
Furthemore, within the data set, there are substantial differences between each countries’
number of defiable events, and the number of NPIs implemented for each of these events.
While most countries have one clear wave of infection during the spring and another
during the fall of 2020, a considerable number of countries only have one definable event.
An example of this is Norway, with the 12th of March being the only day that had more
than one of the NPIs in our sample implemented. In Table 4.1.1 below we present the
actions taken in our event selection process.
Table 4.1: Event Cleaning
Action No. Action Taken Number of Events
1 Identify Events of 2 NPIs or More 107
2 Events With Positiv Growth Rate on Implementation Day 76
3 Merge Events Within a 7 Day-Span 64
4 Complete Sample of Events 64
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Estimation Window
The first time interval to choose in an event study is the estimation window. The purpose
of the estimation window is to estimate the expected progression of the observations in
the sample. Additionally, in order to not be affected by the event, the estimation window
should always be before the event window. Choosing the length of the estimation window
demands precision in balancing. A longer window is preferable as it increases the precision
in what is considered expected progression, while on the other hand a shorter window
is a stronger indicator of the current situation. Even though in finance it is common to
choose an estimation window that ranges from 250 to 30 days before the event occurred,
there is no set length for estimation windows (Aktas et al., 2007).
However, the length of the estimation window will be shorter in the case of an
epidemiological event study. Regrettably, we do not have any available data on COVID-
19 related hospitalizations before the virus started spreading at scale, and NPIs were
implemented. Nonetheless, data prior to the substantial rise in hospitalizations would
not be relevant for our study, since we are considering an expected progression in growth
rate for COVID-19 related hospitalizations during the virus outbreak. Therefore, our
estimation window is set from the date that the NPIs are implemented, until the day the
NPIs are expected to be effective, namely fourteen days.
The determination of the estimation window is rather limited by our data. For many of
the events in our sample, it could be highly beneficial to experiment with an estimation
window that stretched further beyond the day of NPI implementation. This is because
the NPI implementation is a result of rising infections and thereby hospitalizations.
Unfortunately, a substantial part of the countries in our sample started registering the
related hospitalization numbers at the time of NPI implementations. Therefore, a longer
estimation window would greatly reduce the events in our sample.
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Event Window
The next important step in the event study methodology is to establish the event window.
The purpose of the event window is to capture the effect of the event. This can sometimes
be challenging, since it is usually difficult to predict the exact time period in which the
effect of the event is most present. Choosing the length of the event window is, as for
the estimation window, about finding the right balance. A short event window could
potentially exclude some of the NPI effect as well as not account for a potensial random
drop in growth rate. However, if the event window is too long it could potentially include a
time period where the event is no longer effective, as well as include other factors irrelevant
to the event itself.
As mentioned in the Disease progression section of our thesis, the effects of the NPIs
are estimated to occur after 2-3 weeks. Therefore, an appropriate event window is set
to start immediately after the time in which the NPI implementations are expected to
be effective. In order to capture the full effect of the event, we find it reasonable to use
an event window of 14 days. This choice gives us the opportunity to compare two time
periods of identical length in our event study.
Although the length of our event study windows had to be based on assumptions and
doubtable estimates, we find them to be pertinent for the purpose of our paper, in order
to estimate the effect of NPIs on hospitalizations. The event study windows presented in
this section are the ones that will be used for the rest of our analysis. Moreover, we will
test the strength of our assumptions in our Robustness Tests section later in our thesis.
4.2 Estimating Event and NPI Groups Effects
With the intention to build on the event study windows we use the pre- vs. post-treatment
comparison to compare those windows, and to estimate the effect of each event. These
estimated effects will be used in our further analysis. In the following section we will
go over our methodology for identifying and isolating the effects of the events and NPI
groups.
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4.2.1 Pre- vs. Post-Treatment Comparison
When estimating the effect of the implemented NPIs, we use a pre- vs. post-treatment
comparison, a particular type of simple difference evaluation (Pomeranz, 2017). It is an
arduous and uncertain job to identify a standard control group to compare the treatment
with, in this case NPI implementation. This is because NPI implementations take place
in different countries, times and in various stages of the pandemic. Ideally, we would use
a country that has not had any NPIs implemented as a control group, to compare growth
rate in hospitalization. However, since there is no European country that allows us to do
so, we have to compare each country with itself, before and after NPI implementation.
This enables us to evaluate how the growth rate changes over time, and estimate the
difference in growth rate before and after the event/effect date.
While a simple pre-post comparison could lead to biased results, there are certain settings
in which a pre-post analysis can yield credible estimates while only analyzing one group
(Pomeranz, 2017). The key assumption of this method is that the treatment is the only
factor that influenced a change in outcomes over that time period. Without the treatment,
the outcomes would have remained the same. However, this is often not the case in real
life. Over time many factors can affect an outcome, which contradicts the key assumption
made above. Therefore, in order to use this method, we must assume there are no other
systematic changes over time other than the treatment. To account for this, we observe
several different events, in order to cancel out any systematic time-varying components.
The event study windows are also limited to a relatively short time-span, where we
assume that each country’s growth rate would have remained stable without any NPIs
implemented. Therefore, any change in growth rate will be attributed to the treatment.
Furthemore, the benefit of this method is that it does not require information on the
groups that are not receiving treatment. Therefore, we can look at the effects the NPI
implementations have on the individual countries separately.
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4.2.2 OLS-Regression
In order to estimate the NPI effects, we use an ordinary least squares regression (OLS). The
OLS model is a method for estimating a linear regression model, in which the estimates
for the parameters are acquired through a minimization of the sum of squared residuals
(Woolridge, 2018). The residuals are the differences between the observations and the
values of the dependent variable estimated by the OLS model. To answer the hypotheses
of the thesis, we use different OLS models for exploring each hypothesis.
Hypothesis 1: All events of NPI implementation during increasing growth rate in
COVID-19 related hospitalizations will result in a reduced growth rate when the NPIs are
expected to be effective.
For this hypothesis we examine a data set containing all the events and their corresponding
7-day moving average growth rate of hospitalization. Assuming that the effect of the
implementation will be present after 14 days, we include dummy variables into the data
set representing the time after implementation. The model is as presented below:
Gt, the dependent variable represents the 7-day moving average growth rate of COVID-19
related hospitalizations. Week1 is a time dummy variable, and will be 1 for days 1-7 in
the event study window, equal to two weeks prior to the effect date. Week2 will be 1 for
days 8-14 in the event window, equal to one week prior to the effect date. Week3 and
Week4 will follow the same logistics, just after the effect date.
The intercept  0 indicates the average growth rate on the effect date for all events included
as we look at this day separately for this regression. Coefficients  i for each week indicator
represent the average difference for that given week relative to the effect date. We use
this method of comparing averages across all events to be able to grasp an overview of
the development of the growth rate in the period after the introduction of NPIs, relative
to what we assume to be the effect date. Since the events are independent, the average
will give a clear indication of the effect of NPI implementation in general, without saying
anything about which of the events or NPIs that are effective. In order to understand
how effective each event has been, we use a different regression in the following section.
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We view each implementation with different combinations of NPIs as a treatment, and
use a pre vs. post treatment event study to estimate the effect on reducing the growth
rate of COVID-19 related hospitalizations. The effects are estimated using the following
OLS-regression:
The dependent variable Yi, trepresents the 7-day moving average growth rate of COVID-19
related hospitalization for event i. Because we are taking into account a two-period event,
pre- and post treatment, the intercept coefficient  0 represents the average growth rate in
the period before the NPIs are expected to be effective. Furthemore, Aftert is a dummy
variable that indicates whether we expect the effect of the NPIs to have an impact on a
given day. This dummy variable will be “1” for all days after the effect date (14 days after
implementations). Our goal for the regression is to find the coefficient  i for this dummy
variable as an indicator of the effect of the NPI implementation for each event i. This
coefficient will represent the change in 7-day moving average growth rate of hospitalization
after the effect date for event i. With the obtained effects of each event, we are able to
analyse the differences in the events by identifying the NPIs responsible for an effective or
ineffective implementation.
Hypothesis 2: The introduction of any NPI effectively reduces the growth rate of COVID-
19 related hospitalizations, yet some NPIs are more effective than others.
The obtained coefficients representing the effectiveness of the event are included into a
data frame containing the characteristics of the event, e.g. the implemented NPIs for the
given event. We intend to identify the NPIs present in the most successful events, and
look for statistical significance so we can conclude on the effectiveness of the different
NPIs. To do so, we use the following OLS model:
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In this model, Ei represents the effect of the event, given by the coefficient  i from
equation 4.2. Additionally, NPIgroupj represents dummy variables for the different NPI
groups j identified and presented in section 3.1.2, equal to 1 if the given NPI group was
implemented in event i, and 0 otherwise. The intercept  0 represents the expected growth
rate when no NPIs are implemented. Therefore, in order to answer our hypothesis we are
interested in the coefficient  j , that represents the estimated effect NPI group i has on the
7-day moving average of COVID-19 related hospitalizations across all events. Moreover,
we will use this equation in order to investigate our third hypothesis.
Hypothesis 3: Events of NPI implementation in the later stages of the pandemic are
more effective in reducing hospitalizations than events in the first wave.
In order to inspect the difference between the effect of NPIs implemented in the first
pandemic wave, we include a dummy variable into equation 4.3 to indicate whether the
event took place in the spring of 2020 or not. The model is then:
All variables are explained in the section about hypothesis 2, other than the coefficient
and dummy variable for the first wave. With the intent of answering our hypothesis we




In this section of our thesis we present the results of our regressions in order to provide
concrete answers to our hypotheses and respond to our research question: How effective
are Non-Pharmaceutical Interventions in reducing the spread of COVID-19 and thereby
hospitalization numbers?. Our analysis utilizes the event study methodology and consists
of three parts that address our hypotheses. Firstly, we will present the results of our event
specific regression, that show the effect of each NPI implementation event. Secondly, we
will present our NPI specific regression, and reflect on the most effective NPIs in our
study. Lastly, we will present the results of our first wave indicator regression.
5.1 Event Regression
In this part of our empirical results section we present the outcomes of our event regressions.
These regressions refer to our first hypothesis and analyze if the introduction of an NPI
during a period of increasing growth rate in COVID-19 related hospitalizations will result
in a reduced growth rate. Subsequently, in order to analyse the general effect of the
implementations within our event window, we carry out the OLS regression from Equation
4.1. Within this model the 7-day moving average growth rate of hospitalization is the
dependent variable, and the independent variables are dummy variables that represent the
time around the effect date. The results of this regression are displayed below in Figure
5.1.
Figure 5.1: Weekly Average Growth Rate
Note:⇤p<0.1; ⇤⇤p<0.05; ⇤⇤⇤p<0.01
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The results presented in Figure 5.1 indicate a clear reduction in the growth rate of COVID-
19 related hospitalizations during the time after the expected effect of the implemented
NPIs. The week following the implementations, two weeks prior to expected effect, the
results are positive and on average 5.81% higher per day in relation to the effect date.
This growth rate is reduced in the second week, the week prior to the expected effect,
but is still positive with an average of 1.77% per day. The relative growth rate turns
negative in the third week, the week after the expected effect, with an average of -1.76%
each day. Although these results are not statistically significant, they support the belief
that NPIs will have a significant effect after approximately 14 days. The large growth
rate reduction from the first week to the second implies that there is some effect of NPIs
before 14 days. This can be due to the fact that most NPIs are announced to the public
before they are implemented, and this can cause the population to adjust their behaviour
before the official date of NPI implementation. Additionally, it is important to note that
the growth rate is calculated as a 7-days moving average. Therefore, the average of one
week is influenced to a certain degree by both the previous and subsequent week.
Furthermore, the regression reveals that the average decrease in growth rate per day
increases from the third week to the fourth by -3.48%, suggesting a larger effect of the
NPIs longer after they were implemented. From the outcome of our analysis, the results
strongly indicate that the implementation of NPIs have a reducing effect on COVID-19
related hospitalizations. In order to identify the NPIs responsible for the effect, we find it
necessary to carefully study each individual event. Figure 5.2 below presents the results
of our regression from Equation 4.2. The coefficients represent the relative reduction of
people hospitalized with COVID-19, within the event period compared to the estimation
period of our event study.
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Figure 5.2: All Event Coefficients
Note:⇤p<0.1; ⇤⇤p<0.05; ⇤⇤⇤p<0.01
The plots presented above are limited to convey changes in growth rate within -0.2 and 0.2,
in order to illustrate the confidence intervals for the “smaller” impact events. Therefore,
the effects of some events are not present in the figures above, as the effects exceed the
displayed interval. These events includes the implementations of NPIs in Czechia on
2020-03-13 (-0.356***), Estonia on 2020-03-13 (-0.202***), Luxembourg on 2020-03-18
(-0.399***), Norway on 2020-03-12 (-0.219***) and Sweden on 2020-03-15 (-0.276***).
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From the results of Figure 5.2, it is clear to say that according to the regression results, not
all NPIs implementations have been successful in reducing the spread of the coronavirus
and subsequently the daily COVID-19 related hospitalizations. For instance, in comparison
to our estimation period, for the NPIs implemented in the Netherlands on 2020-08-18 and
in the United Kingdom on 2020-05-28, we see that there is an increase in the growth rate
of hospitalizations in our event period. The difference in effects of each event will be the
basis for further investigating the effect of the individual NPI groups.
5.2 NPI Regression
In this part of our analysis, we quantify the effect of each NPI grouping. Our objective is to
analyze our second hypothesis, which states that all the NPIs in our sample are effective in
reducing the growth rate of COVID-19 related hospitalizations. Additionally, we intend to
discover which NPI groups are the most effective. In order to do so, we use the estimated
event effects from our previous regression as the dependent variable in Equation 4.3, and
we include the dummy variables for each NPI grouping as the independent variables. In
Figure 5.3 below we present the result of the regression.
Figure 5.3: Regression Outcome NPI Group Specific Variables
Note:⇤p<0.1; ⇤⇤p<0.05; ⇤⇤⇤p<0.01
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Although a regression analysis might not be able to give us the results to arrive at
an absolute conclusion, it offers us a clear indication on which NPI groups are most
significantly reducing the growth rate of daily hospitalizations in the event period of
our study. Our model demonstrates that both high and low intensity of school closures
are effective in reducing the COVID-19 related hospitalization numbers. Low intensity
school closings indicating a 5.35% reduction of hospitalization and high intensity school
closings indicating a 9.53%. These results coincide with contemporary research on the
virus, which confers that the youth is the main spreader of the virus, due to many of
the infected being asymptomatic. As an example, we refer to the remarks made by Dr.
Takeshi Kasai at a WHO press conference (2020); who stated that the asymptomatic
youth is increasingly driving the speed of the pandemic, with many of them being unaware
that they are infected.
Lastly, the final significant coefficient of our regression is the NPI StayHomeOrder,
that is more commonly known as the “lockdown measure”. A significant reduction in
hospitalizations from this NPI was expected, as it is one of the more intrusive NPIs.
However, it is surprising that the reduction is as low as 5.35%, as one would expect it to
be more effective than school closures. The relatively low effect of lockdown measures
could be a result of possible side effects of this NPI. One side effect being, as stated in a
study by Stanford researchers, that “it is possible that stay-at-home orders may facilitate
transmission if they increase person-to-person contact where transmission is efficient such
as closed spaces” (Bendavid et al., 2020). In countries where generation housing is more
common, a lockdown could result in the youth spending more time with the elderly.
Additionally, another side effect with the StayHomeOrder is that the enforcement of
this NPI varies greatly between countries (BBC, 2020). It is also clear from our NPI
implementation overview in section 3.2.1 that StayHomeOrder is often implemented at
the same time as other NPIs, meaning that the strictness of the lockdown measure might
be low. If the implementation of the StayHomeOrder NPI resulted in a full lockdown,
other NPIs would have been excessive.
30 5.3 First Wave Indicator
Furthermore, our regression demonstrates a clear indication that the lockdown measure
and school closings are effective in reducing the spread of the virus. However, it is also
important to consider the indications of effect of the other variables in our analysis.
As expressed in our second hypothesis, we believed that all NPIs would be effective in
reducing COVID-19 related hospitalizations to a certain degree. Nevertheless, the variables
WorkRestrictions and CloseVBHigh imply the contrary. Although distinct conclusions
are hard to obtain, our extensive analysis concludes that the measures stated above are
ineffective in reducing the growth rate of daily hospitalization numbers.
To conclude, our regression suggests that not all NPIs are as effective in reducing the growth
rate of COVID-19 related hospitalizations. The model indicates that strong restrictions on
school closures result in a 9.53% reduction in the growth rate of hospitalized COVID-19
patients, and lockdown measures a 5.35% reduction. These percentages demonstrate that
these two measures are the most effective NPI groups to implement in order to effectively
reduce the spread of the virus. In accordance with our research, a recent study by BMC
Medicine indicates that restrictions imposed on schools were found to be more effective
than internal movement restrictions, such as lockdown (Liu et al, 2021).
5.3 First Wave Indicator
In the final part of our empirical results section we introduce the First wave indicator
variable in our regression. The objective of this variable is to investigate whether events
in the later stages of the pandemic are more effective in reducing the growth rate in
COVID-19 related hospitalizations, as suggested by our third hypothesis. Figure 5.3 below
shows the result of our regression with the “First wave indicator” variable.
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Figure 5.4: Regression Outcome With First Wave Indicator Variable
Note: ⇤p<0.1; ⇤⇤p<0.05; ⇤⇤⇤p<0.01
The results of the regression strongly indicate that our initial hypothesis is disproven. In
the regression the estimated coefficient for the variable is -0.083, with significant p-values
below the 0.1% level. These results demonstrate that a substantial part of the most
effective events in our sample are from the first wave of the pandemic. The First wave
indicator is the variable in our regression that results in the greatest reduction in growth
rate in daily COVID-19 related hospitalizations. This result suggests that one of the most
important factors in NPI implementations is to apply strict regulations early in the first
wave of infection. This early application is to avoid implementations in the second wave,
where the NPIs seem to be less effective. The results of the regression contradicts our
initial hypothesis, in which we assumed that the use of NPIs would be more effective later
on in the pandemic. To further analyze our initial hypothesis, we detected three grounds
that could explain its seemingly erroneous nature.
Firstly, the events later on in the pandemic do not account for already active NPIs, as
our events are only defined by the NPIs implemented at that specific time. Therefore,
later events are lacking contributions from NPIs that would greatly impact both the event
study windows and reduce the effect of these events.
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Secondly, the effectiveness of NPIs might be reduced by factors unrelated to the NPIs
themselves. One of them being the pandemic fatigue, a drop in adherence to Non-
Pharmaceutical Interventions. In a recently published research in the medical journal
YAMA, the authors estimate the effect of pandemic fatigue (Crane et al., 2021). The
results of this research indicated a substantial reduction in adherence to response measures
that reduced social contact. The only NPI that had increasing adherence from April until
November 2020, was the use of masks and other face coverings.
Lastly, it is important to mention another possible contributing factor to the reduction
in effectiveness of the NPIs in later stages of the pandemic, namely virus mutations.
Throughout the pandemic we have seen new varieties of the COVID-19 virus, such as the
mutations commonly referred to as the “British mutation” and “South African mutation”
that originated in December 2020. These are mutations that have shown to have higher
transmissibility than the earlier varieties of the virus (WHO, 2020). Therefore, it can be
deduced that NPIs might be less effective in areas whereas a new mutation is dominating
the infections.
In conclusion, the results of our First wave Indicator regression reveals that the NPIs
were most effective in the first wave of the pandemic. This final regression concludes
our Empirical Results section. In order to further solidify the conclusions drawn from




In this part of our thesis, we will conduct robustness tests to observe how our results
react to changes in the specifications and assumptions in our model. In the first section
we test our assumption of a 14-day delay, from NPI implementation to event/effect day,
by introducing alternative days until the expected effects appear. In the second section
we test alternative lengths of the two event study windows.
6.1 Alternative Expected Day of Effect
This thesis conducts analysis based on the assumption that the NPIs are effective after 14
days from implementation. In this part of our thesis we test the strength of our analysis
and challenge this assumption.
Therefore, in this section we test different time intervals from NPI implementation until
the NPI are expected to be effective. The robustness testing in this section is conducted
only to assess the time interval in question. All other conditions and assumptions are
constant. This conveys that, in this test, the length of the event study windows are kept
at 14-days.
On the left side of Table 6.1 we set days after NPI implementation. The rates presented
on the right side of the table presents the outcomes of our test, namely the difference in
growth rate in hospitalizations between the two event study windows. All tests are based
on the average event coefficients for all events in our sample.
Table 6.1: Alternative Interval of NPI Implementation Effect
Interval from NPI Implementation Event Study Event Coefficient
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In Table 6.1 above we see the result of testing with longer time-delay from NPI
implementation to NPI effect. We observe that an increase in this delay from 14 to
16 and 18 days, decreases the average event coefficient. This means that increasing the
time delay apprehends less of the effect of the NPI implementation.
This robustness test only analyzes the change in event coefficients for longer time delays.
Testing for shorter time delays could be beneficial for our analysis. The difficulty with
such a test is that we would be unable to conduct tests where the estimation window
precedes our current day of NPI implementation. This is because of data availability,
as many countries only started registering their daily COVID-19 related hospitalization
numbers on the same day as they introduced their initial measures. Testing for 12 days
until expected effect with a 14 day estimation window, would result in a great reduction
of events in our sample. In a case of less events in our regression, the results of robustness
tests would be uncomparable. Reducing the length of only the estimation window is not
considered an option in this part of our robustness analysis, because the effect window
should not be longer than the estimation window (Aktas et al. 2007).
Additionally, in order to strengthen our analysis, we include a scenario where we assume
that it would take the NPIs 12 days to show significant effects. We limit our estimation
and event window to 12 days prior and after the effect date. We reduce the event window
to 12 days in order to handle the missing data prior to the day of NPI implementation
from the earliest events. We apply this reduction in order to understand and observe
what effects a shorter interval could have on our thesis analysis.
Table 6.2: 12 Day Interval Of NPI Implementation Effect
Interval from NPI Implementation Event Study Event Coefficient
Until Event/Effect Day Windows Length Average
12 12 -0.05944
As it can be seen in Table 6.2 above, reducing the number of days to 12-days increases
the average event coefficient. We disregard this option considering that for our event
regressions we aim to have coefficients as negative as possible.
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6.2 Alternative Event Study Windows
In our second robustness test, we adjust the length of our event study windows. In our
preliminary analysis, the initial length of the estimation window and event window is
set to be 14 days. In this section of our robustness test we run our event regressions on
different event study windows. Testing different event study windows is crucial in order
to see if we are able to capture the maximum effect of our events.
This robustness test will only test for different lengths of the event study windows, where
we deduct that the assumption of 14 days from NPI implementation to event/effect day
holds. Furthemore, our testing will keep the estimation window and event window at the
same length, in order to keep the test results comparable to our initial analysis.
In Table 6.3 below we present the results we found by changing the length of our event
study windows. On the right side of the table we present the event regression coefficients
associated with the respective changes.
Table 6.3: Alternative Event Study Windows
Interval from NPI Implementation Event Study Event Coefficient





The event coefficients from the table above displays that reducing the number of days
in the event study windows results in lower relative difference in event effect, between
the estimation window and the event window. A lower coefficient shows that more of the
effect of the NPI implementations is captured. Therefore, reducing the number of days in
our event study windows would not improve our model.
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Optimally, this robustness test would also include testing for event study windows of more
than 14 days. However, as mentioned in the robustness test above, due to lack of available
COVID-19 related hospitalization data we are unable to test for estimation windows that
stretch before the day of NPI implementation. The maximum time span of our estimation
window with a 14 day lag until expected effect is then 14 days. Furthemore, increasing the
number of days in our event study windows increases the possibility of effects irrelevant
to the NPI implementation.
Our robustness testing could have been conducted under more fixed conditions. Meaning
that we only test for events that have data available for a longer time period before the
NPI implementation. More fixed conditions could have given us the opportunity to test
longer time intervals for our event study windows. However, seeing that the events we
would have to exclude from our analysis would mostly be events from the first wave of
infections, we decided not to conduct this type of analysis. Due to the first wave events
being the most effective ones, and containing the most NPIs implemented.
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7 Limitations
In this part of our thesis we assess our data critically by discussing the size and data
reliability of our sample. Furthermore, other limitations of our study are outlined by
discussing factors of epidemiological growth and other relevant missing factors that could
be relevant for our analysis.
7.1 Small Sample
A limitation within our thesis is our small sample size. As a result of our small sample size,
of only 64 event observations, we reduced the number of NPI variables in order to adjust
for a greater fit in our regression. A larger sample would have enabled us to use variables
for every NPI in our response measures dataset and could have resulted in more precise
results. Although 64 observations are sufficient in order to calculate the effectiveness of
the events, we encountered a challenge in regards to our NPIs. While a large part of our
NPI group of dummy variables were active in half our sample, others were only active in
a fourth. This challenge becomes clear in regards to conducting other regression methods.
Therefore, regression methods such as Lasso Regression are excluded from our analysis.
The reason behind the lack of a larger sample size is the absence of available data from
numerous EU territories. Available data from all European countries would greatly
increase our sample size, and subsequently result in more reliable estimates and stronger
conclusions. To our surprise, considering their size and reputation, data that was necessary
to our research was unavailable from countries like Finland and Germany. Therefore,
the lack of data on hospitalization and measures is primarily due to the exclusions of
data-deficient countries from our sample.
Our sample size could also have been expanded by including non-European countries
like South Korea, China, Iran and USA. However, it was arduous to find comparable
response measures in regards to data, as well as reliable statistics on hospitalizations
for non-European countries. The collection of uncertain and uncomparable data could
have made our findings inconsistent. Therefore, we chose to limit our data to European
countries because the comparability advantage of the response measures outweighs the
advantage of having data from countries outside the EU.
38 7.2 Unreliable Data
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The second limitation of our analysis is the lack of reliable data. The response measures
data set has restrictions because the data is based on a manual collection and sorting process
of measures that are collected from numerous external sources. It is districtly probable
that data might be absent and that source material might have been misinterpreted.
Additionally, daily COVID-19 related hospitalizations, our main component of data, is
at even greater risk of being unreliable. It is reasonable to believe that, within health
institutions, the counting system of COVID-19 cases could be more prone to error because
of the unprecedented pandemic. Furthemore, another limitation in the daily COVID-19
related hospitalizations data is that it fails to take into consideration that a reduction in
number of hospitalizations is not necessarily due to the effectiveness of NPI measurements,
but on the other hand could be due to a result of COVID-19 fatalities. Initially, our
objective was to use the growth rate of daily hospital admissions as our dependent variable.
However, only 11 countries had this data available, and some of them for only a brief
period of time. Therefore, in order to go forward with our analysis, we were obligated to
prioritise a larger sample over a more reliable dependent variable.
7.3 Epidemiological Growth
Another limitation within our analysis is that our model does not include a control group
that regulates how the epidemic curve of the COVID-19 virus would naturally bend
without any NPI intervention. Presented in the regression results section above, our
model indicates, with a constant value of 0.019, that hospitalization numbers would grow
exponentially. Yet, this is not the case because every epidemic curve is self-limiting in
the long run (Kleczkowski & Kao, 2020). However, within the short time spans in which
we conduct our analysis, we choose to allocate all the reduction in the growth rate of
hospitalizations to NPIs. Furthermore, it is likely that other factors within the field of
epidemiology are disregarded in our thesis. As this thesis is conducted from a purely
empirical point of view, and not from the view of experts in epidemiology.
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7.4 Missing Relevant Factors
Accounting for all relevant factors related to the spread of COVID-19 and the effects of
NPIs requires a substantially larger model than the one used in this thesis. Our analysis
introduced some broad assumptions, excluding numerous factors. It is a possibility that our
analysis has overlooked relevant factors that could have greatly influenced the effectiveness
of the NPIs in our sample. For example, a factor being the cross-sectional effect, that
could have estimated the effect of combining NPIs to reduce the growth rate of COVID-19
related hospitalizations. Considering the results in our analysis regarding the first wave
indicator, it is likely to assume that cross-sectional effects between NPIs are responsible
for a considerable reduction during the first wave of the pandemic.
We believe that most country-specific factors, such as the age demographic, population
health and population density, are irrelevant for our analysis. This is because the effect of
these factors should be equal in the estimation window and the event window. However,
some factors that directly contribute to the effectiveness of the NPIs are likely to be
absent from our analysis. One of these factors could be the reliance that the population
has on those who are responsible for implementing restrictions, such as the government
and health authorities. Additionally, a contributing factor can be differences in the level
of enforcement of the NPIs within different countries, and if the implementation is based
on the population’s trust or its fear of monetary fines or other repercussions.
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8 Conclusion
Our objective within this thesis has been to expand the currently available research with
information about the effect of NPIs in reducing the spread of COVID-19 and thereby
lowering hospitalization numbers. Furthermore, by quantifying the effects of NPIs, we
aim to provide crucial input for a cost-benefit analysis regarding pandemic responses.
Firstly, we used an event-driven approach to estimate the effects of 10 NPI groups on
COVID-19 related hospitalizations in 25 European countries. We identified 64 events
across these countries, which we used to explore our hypotheses. Firstly, we looked at
Hypothesis 1, concerning the general effect of NPI implementations. From our results
we saw a reduction in the growth rate of COVID-19 related hospitalizations after NPI
implementation, which supported our first hypothesis and the general belief that NPIs
reduce the spread of COVID-19. By using the pre-vs post-comparesaint method, we
estimated the effect for each of the 64 events.
Secondly, we combined the effect of each event with their corresponding implemented NPIs,
to quantify the effect of each individual NPI group. This was done to answer our second
hypothesis that all NPIs are effective, while some are more effective than others. We found
the NPI group "SchoolCloseHigh", regarding high intensity of school closing, to have the
highest significant effect. Reducing the growth rate of COVID-19 related hospitalizations
by 9.53%. Other NPI groups with significant effect were "SchoolCloseLow" regarding low
intensity of school closings and the lockdown NPI "StayHomeOrder", reducing the growth
rate respectively by 4.58% and 5.35%. We were not able to estimate the effect of the other
NPI groups presented in our regression with a significance level of 0.05, however, most
NPI groups indicated a reduction in growth rate.
Lastly, we looked at our third hypothesis which states that events of NPI implementation
in the later stages of the pandemic were more effective in reducing COVID-19 related
hospitalizations than events in the first wave. Our results indicate the opposite. They
stipulate that the NPIs introduced in the first wave seemed to be the most effective.
We argue that potential reasons for this can be “pandemic fatigue”, causing a drop in
adherence to NPIs. Furthemore, another reason can be the reduced effect of individual
NPI groups, when other NPIs are already active.
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In conclusion, with our thesis we hope to add some groundwork to the already available
research regarding the effectiveness of NPIs. We desire to do so in order to enable
governments and policy makers to construct more informed decisions in the future. If
more effective response measures will be chosen in the wake of a future pandemic, we
firmly believe that lives will be saved and economic consequences will be minimized.
Further research
In order for future research to accurately estimate the effects that Non-Pharmaceutical
Interventions have had on reducing COVID-19 related hospitalization numbers, we
elaborate three propositions.
Firstly, even though we argue for the use of daily COVID-19 related hospitalizations
as the dependent variable, a more accurate time specific variable could be the daily
hospital admission of COVID-19 patients. We believe hospital admissions to be the most
trustworthy dependent variable for this type of analysis as it is not affected by the time
spent at the hospital by each patient. However, not enough countries register this kind of
data. For statisticians and researchers to be able to conduct analysis on this variable in the
future, it is necessary that health authorities and hospitals set a plan for a more accurate
registration of daily hospital admissions. Through our data collection process, several
health authorities indicated that these numbers will become available soon, opening up
the opportunity for this variable to be used in future analysis.
Secondly, there is a great necessity for further research on the interval from NPI
implementation to when they are expected to be effective. During our information
collection process we corresponded by email with the Norwegian Institute of Public Health
(NIPH) about this subject. Regrettably, they did not have a clear response to our question.
However, NIPH displayed interest in collaborating with us on this particular issue if we
were to further extend our research beyond our thesis. Their profound interest made us
understand even further the contemporary necessity for this kind of research.
Lastly, we believe that, in future analysis, researchers should aim to include cross-sectional
effects between NPIs. In order to include more variables in the analysis, the quantity of
data must increase in scope. This type of research could have the ability to find the most
effective combination of NPIs to reduce the spread of COVID-19.
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AdaptationOfWorkplace Adaptation of workplaces
(e.g. to reduce risk of transmission)
BanOnAllEvents Interventions are in place to limit all
indoor/outdoor mass/public gatherings
ClosDaycare Closure of educational institutions:
daycare or nursery
ClosHigh Closure of educational institutions:
higher education
ClosPrim Closure of educational institutions:
primary schools
ClosSec Closure of educational institutions:
secondary schools
EntertainmentVenues Closure of entertainment venues
GymsSportsCentres Closure of gyms/sports centres
HotelsOtherAccommodation Closure of hotels/accommodation services
IndoorSmallGatherings
Indoorover50 Interventions are in place to limit indoor
mass/public gatherings of over 50
participants
Indoorover100 Interventions are in place to limit indoor




Indoorover500 Interventions are in place to limit indoor
mass/public gatherings of over 500
participants
Indoorover1000 Interventions are in place to limit indoor
mass/public gatherings of over 1000
participants
MassGather50 Interventions are in place to limit indoor
mass/public gatherings (any interventions
on mass gatherings up to 50 participants
included
MassGatherall Interventions are in place to limit indoor
mass/public gatherings (any interventions
on mass gatherings up to 1000 participants
included
NonEssentialShops Closures of non-essential shops
OutdoorSmallGatherings
Outdoorover50 Interventions are in place to limit outdoor
mass/public gatherings of over 50
participants
Outdoorover100 Interventions are in place to limit outdoor
mass/public gatherings of over 100
participants
OutdoorLargeGatherings
Outdoorover500 Interventions are in place to limit outdoor
mass/public gatherings of over 500
participants
Outdoorover1000 Interventions are in place to limit outdoor
mass/public gatherings of over 1000
participants
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PlaceOfWorship Closure of places of worship
PrivateGatheringRestrictions Restrictions on private gatherings
RestaurantsCafes Closure of restaurants and cafes/bars
SocialCircle Social circle/bubble to limit social contacts
e.g. to limited number of households
StayHomeGen Stay-at-home recommendations for the
general population (which are voluntary or
not enforced)
StayHomeOrder Stay-at-home orders for the general
population (these are enforced and also
referred to as ‘lockdown’)
Teleworking Teleworking recommendation
StayHomeRiskG Stay-at-home recommendations for risk
groups or vulnerable populations (such as
the elderly, people with underlying health
conditions, physically disabled people, etc.)
WorkplaceClosures Closures of workplaces
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Table A0.1: Weekly Average Growth Rate
Growth Rate
Predictors Estimates CI P-value
(Intercept) 0.04 0.01 - 0.06 0.002
Week 1 0.06 0.03 - 0.08 <0.001
Week 2 0.02 -0.01 - 0.04 0.151
Week 3 -0.02 -0.04 - 0.01 0.153
Week 4 -0.03 -0.06 - -0.01 0.005
Observations 1796
R2/R2adjusted 0.130 / 0.128
Table A0.2: Main NPI Regression
Coefficient
Predictors Estimates CI P-value
(Intercept) 0.02 -0.02 - 0.06 0.354
ScoolCloseLow -0.05 -0.08 - -0.01 0.015
ScoolCloseHigh -0.10 -0.14 - -0.05 <0.001
WorkRestrictions 0.00 -0.04 - 0.05 0.856
CloseVBLow -0.00 -0.05 - 0.04 0.933
CloseVBHigh 0.03 -0.04 - 0.10 0.425
PrivateGatheringRestrictions -0.01 -0.05 - 0.03 0.504
StayHomeRec -0.02 -0.07 - 0.03 0.498
GatheringsLow -0.03 -0.08 - 0.01 0.130
GatheringsHigh -0.02 -0.06 - 0.02 0.433
StayHomeOrder -0.05 -0.10 - -0.00 0.038
Observations 64
R2/R2adjusted 0.450 / 0.346
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Table A0.3: First Wave indicator
Coefficient
Predictors Estimates CI P-value
(Intercept) 0.02 -0.02 - 0.05 0.399
ScoolCloseLow -0.04 -0.07 - -0.00 0.029
ScoolCloseHigh -0.06 -0.10 - -0.02 0.006
WorkRestrictions 0.02 -0.02 - 0.05 0.386
CloseVBLow -0.01 -0.05 - 0.03 0.608
CloseVBHigh 0.02 -0.04 - 0.09 0.512
PrivateGatheringRestrictions -0.00 -0.04 - 0.03 0.862
StayHomeRec -0.00 -0.05 - 0.04 0.916
GatheringsLow -0.03 -0.06 - 0.01 0.196
GatheringsHigh 0.01 -0.03 - 0.04 0.762
StayHomeOrder -0.05 -0.10 - -0.01 0.021
First Wave Indicator -0.08 -0.12 - -0.04 <0.001
Observations 64
R2/R2adjusted 0.578 / 0.489
